|
2910 7th St. Berkeley, CA 94710 CA Tel. 510-204-7200 Toll Free 800-246-9662 Fax 510-644-0537 |
Type: Public
On the web:
http://www.xoma.com
Employees:
230
Employee growth: 17.9%
XOMA doesn't want to toil in anonymity. Instead, the company pairs with larger drug firms to develop and market its products, primarily monoclonal antibodies (biotech drugs based on cloned proteins). The firm partners on therapeutics for cancer, infectious disease, inflammatory ailments, and autoimmune conditions; it also receives royalties on drugs developed by companies that have licensed its technologies. XOMA has collaborative agreements with companies and entities such as Takeda Pharmaceutical, Merck, and the National Institutes of Health (to find treatments for bioterrorism threat botulinum). In addition, the company has some proprietary candidates for metabolic and oncology applications.
Key numbers for fiscal year ending December, 2010:
Sales: $33.6M
One year growth: (65.8%)
Net income: ($68.8)M
Officers:
Chairman, President, and CEO: Steven B. Engle
VP Operations: Robert S. (Rob) Tenerowicz
VP Finance and CFO: Fred Kurland
Competitors:
MedImmune
Novartis
Regeneron Pharmaceuticals
Halted. Market Data powered by